The first self-injectable HIV antibody, PRO 140, has a 98 percent success rate in reducing the virus in HIV patients’…
Read More
The first self-injectable HIV antibody, PRO 140, has a 98 percent success rate in reducing the virus in HIV patients’…
Read MoreDrugmaker Merck & Co. has granted a free license allowing one of its HIV medicines to be made and sold…
Read MoreA unit of Hain Celestial Group Inc. is recalling some peanut and almond butter because of possible salmonella contamination. The…
Read More